OBVIUS Robotics, Inc. Secures $10M in Series A Funding for Revolutionary Healthcare Innovation

OBVIUS Robotics, Inc., an innovative early-stage start-up, has successfully raised an impressive $10 million in its latest funding round, a testament to the potential impact of its pioneering technology. Established with a vision to transform a medical procedure that has been performed over 7 million times annually in the United States for over four decades, OBVIUS Robotics is set to revolutionize central venous catheterization and vascular access. The company is currently in the process of developing its state-of-the-art, hand-held image-guided CERTA Access System, which aims to enhance patient outcomes while significantly improving ease of use and minimizing risks associated with traditional methods. With this new capital infusion, OBVIUS Robotics is committed to building a team of top-notch professionals who share the company’s passion for innovation and excellence in the healthcare sector. The funding will not only accelerate the product’s commercialization but also help in expanding the team, bringing together talented individuals who are eager to contribute to a groundbreaking solution that addresses a critical need in modern medicine. By leveraging cutting-edge technology, OBVIUS Robotics is poised to make a lasting impact on the medical field, and this funding highlights the strong belief investors have in the company’s vision. If you are seeking an opportunity to be part of something transformative, we invite you to join us on this exciting journey, where you can work on solutions that will shape the future of patient care.